Grassley on President Trump’s Endorsement of the Prescription Drug Pricing Reduction Act

Webp adobestock 223399507
Adobe Stock

Grassley on President Trump’s Endorsement of the Prescription Drug Pricing Reduction Act

The following press release was published by the United States Committee on Finance Ranking Member’s News on Feb. 5, 2020. It is reproduced in full below.

Last night, in his State of the Union address, President Trump called on Congress to put bipartisan legislation to lower prescription drug prices on his desk.

Here are the facts. The House is controlled by Democrats. The Senate requires bipartisanship to get any legislating done. There are only a couple months left before campaign season will likely impede anything from being accomplished in Congress.

So the time to act is now. I’m calling on my colleagues on both sides of the aisle to get off the sidelines and work with me and Senator Wyden, as President Trump already is, to heed that call to action and pass the Prescription Drug Pricing Reduction Act.

It’s the only significant bipartisan bill in town. President Trump, the AARP and the libertarian CATO think tank have all endorsed it.

If you’re serious about fulfilling promises to lower drug costs, my office door is open. It’s time for the Senate to act.

Source: Ranking Member’s News

More News